company background image
AMBF.F logo

Ambu OTCPK:AMBF.F Stock Report

Last Price

US$17.30

Market Cap

US$4.1b

7D

0%

1Y

n/a

Updated

26 Apr, 2024

Data

Company Financials +

AMBF.F Stock Overview

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide.

AMBF.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Ambu A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ambu
Historical stock prices
Current Share Pricekr.17.30
52 Week Highkr.17.48
52 Week Lowkr.9.91
Beta0.87
1 Month Change2.67%
3 Month Changen/a
1 Year Changen/a
3 Year Change-69.11%
5 Year Change-35.45%
Change since IPO-60.68%

Recent News & Updates

Recent updates

Shareholder Returns

AMBF.FUS Medical EquipmentUS Market
7D0%1.6%1.0%
1Yn/a-1.4%21.9%

Return vs Industry: Insufficient data to determine how AMBF.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how AMBF.F performed against the US Market.

Price Volatility

Is AMBF.F's price volatile compared to industry and market?
AMBF.F volatility
AMBF.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: AMBF.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine AMBF.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19374,600Britt Jensenwww.ambu.com

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Ambu A/S Fundamentals Summary

How do Ambu's earnings and revenue compare to its market cap?
AMBF.F fundamental statistics
Market capUS$4.13b
Earnings (TTM)US$34.24m
Revenue (TTM)US$704.54m

120.6x

P/E Ratio

5.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMBF.F income statement (TTM)
Revenuekr.4.90b
Cost of Revenuekr.2.11b
Gross Profitkr.2.79b
Other Expenseskr.2.55b
Earningskr.238.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 14, 2024

Earnings per share (EPS)0.89
Gross Margin56.97%
Net Profit Margin4.86%
Debt/Equity Ratio0%

How did AMBF.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.